Epazume Trademark Details
Word Mark | Epazume |
---|---|
Status | Dead 606 — Abandoned - No Statement of Use Filed |
Current Owner
Teva Pharmaceuticals USA, Inc. of Horsham, PA
View all trademarks for Teva Pharmaceuticals USA, Inc.Serial Number | 85927156 |
---|---|
Status Date | Monday, April 6, 2015 |
Filing Date | Monday, April 6, 2015 |
Correspondent
HERSCHEL PEREL
TEVA PHARMACEUTICALS USA, INC.
425 PRIVET RD
HORSHAM, PA 19044-1220
TEVA PHARMACEUTICALS USA, INC.
425 PRIVET RD
HORSHAM, PA 19044-1220
Case File Statements
Goods & Services | Pharmaceutical preparation and substance for human use in the emergency treatment of anaphylaxis in Class 5 |
---|---|
Goods & Services | Pharmaceutical injection device for human use in the emergency treatment of anaphylaxis in Class 10 |
Classifications
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Thursday, May 16, 2013 |
Primary Code | 005 |
International Class Codes |
010
|
---|---|
U.S. Class Codes | 026, 039, 044 |
Status | 6 — Active |
Status Date | Thursday, May 16, 2013 |
Primary Code | 010 |
Trademark Timeline
-
May 09 2013Trademark application filed with USPTO
-
May 13 2013New Application Entered In Tram
-
May 16 2013New Application Office Supplied Data Entered In Tram
-
Jun 04 2013Assigned To Examiner
-
Jun 05 2013Approved For Pub - Principal Register
-
Jun 19 2013Notification of Notice of Publication E-Mailed
-
Jul 09 2013Official Gazette Publication Confirmation E-Mailed
-
Jul 09 2013Published For Opposition
-
Sep 03 2013Noa E-Mailed - Sou Required From Applicant
-
Jan 10 2014Extension 1 Granted
-
Jan 10 2014Extension 1 Filed
-
Jan 10 2014Teas Extension Received
-
Jan 14 2014Notice of Approval of Extension Request E-Mailed
-
Jul 15 2014Extension 2 Granted
-
Jul 15 2014Extension 2 Filed
-
Jul 15 2014Teas Extension Received
-
Jul 17 2014Notice of Approval of Extension Request E-Mailed
-
Apr 06 2015Abandonment Notice Mailed - No Use Statement Filed
-
Apr 06 2015Abandonment - No Use Statement Filed